Stay updated with breaking news from Ongoing Business Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZURICH, SWITZERLAND / ACCESSWIRE / December 29, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...
In a letter to shareholders, the CEO of NLS Pharmaceutics Ltd recapped the company’s progress and pitfalls for 2023.
Zürich, Switzerland, December 29, 2023 - NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for...